DRV/r 400mg+50mg tabs/PAC-60 No CTN

General Description
Darunavir 400mg + Ritonavir 50mg film coated tablets, in a bottle pack of 60 without outer carton

Technical specifications
Each film coated tablet contains a fixed boosted protease inhibitor combination of Darunavir 400mg + Ritonavir 50mg in a heat stable formulation.

Therapeutic class
Protease Inhibitor

Dosage, Instructions for use: Please refer to the guideline WHO Model Formulary 2008: https://www.who.int/selection_medicines/list/WMF2008.pdf
For more details, please see WHO treatment guidelines www.who.int/hiv/pub/guidelines/en/i ndex.html and WHO Essential Medicines Library www.who.int/emlib/ or your regional/national guidelines.

Details about paediatric dosage schemes can be found at http://www.who.int/hiv/ topics/paediatric/en/index.html

WHO generic tool for assessing paediatric ARV dosing
http://www.w ho.int/hiv/paediatric/generictool/en/

Shelf life: 24 months

Storage conditions:
Do not store above 30°C

Component of a KIT: No